Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting

BACKGROUND: This study was designed to mainly evaluate the activity and safety of olanzapine compared with 5-hydroxytryptamine3(5-HT(3)) receptor antagonists for prevention of chemotherapy-induced nausea and vomiting(CINV) in patients receiving highly or moderately emetogenic chemotherapy (HEC or ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Lijun, Liu, Jiangtao, Liu, Xiuli, Chen, Jie, Yan, Zhijun, Yang, Huifen, Zhang, Daxin
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2761865/
https://www.ncbi.nlm.nih.gov/pubmed/19775450
http://dx.doi.org/10.1186/1756-9966-28-131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2761865/
https://www.ncbi.nlm.nih.gov/pubmed/19775450
http://dx.doi.org/10.1186/1756-9966-28-131

Ejemplares similares